You are now leaving the Kedrion Corporate site. The information available in your chosen website may not be in compliance with EU legislation regulating the advertising of medicinal products for human use, nor do the opinions expressed necessarily reflect the Company’s positions or are endorsed by it.
NO
YES

HIGHLIGHTS

EVENTS

Leading medical-scientific event on Hemophilia held in Trieste, Italy

Kedrion-organized congress put replacement therapy, personalization and access to care in the spotlight

read more 

EVENTS

Kedrion scientific symposium at the 2019 PNS Conference in Genoa, Italy

A chance for world Key Opinion Leaders to debate possible new therapies for the treatment of CIPN

read more 

PLASMA & BIOTHERAPIES

First patient enrolled and treated in Kedrion’s CARES10 clinical study

Phase 3 study to assess efficacy, safety and pharmacokinetics of a 10% IVIg in the treatment of adult PID patients

read more 
  1. EVENTS - 18-10-2018

    EIGHT, the global educational initiative on Hemophilia A and its treatment

    Experts from all over the world attended the EIGHT 2018 Conference in Budapest, Hungary on 12-13 October

    read more 
  2. EVENTS - 02-10-2018

    Kedrion Biopharma participates in the Mother and Child Conference in Moscow

    A 50 years of Anti-D dedicated programme presented at the main Russian congress of Gynecology and Obstetrics

    read more 
  3. CORPORATE - 05-09-2018

    Kedrion joins Rhesus Solution Initiative (RSI) symposium in Lagos

    Nigeria to advocate for Rh Disease universal eradication

    read more 
  4. EVENTS - 08-08-2018

    Kedrion Joins Annual PNS Conference on Neurology

    The company took part in the event with a booth and a delegation of 40 int’l guests

    read more 

Pages

For more information please contact: pressoffice@kedrion.com